SGLT2 Inhibitors and Kidney and Cardiac Outcomes According to Estimated GFR and Albuminuria Levels: A Meta-analysis of Randomized Controlled Trials

RATIONALE & OBJECTIVE: There are few data on the absolute effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors, despite their importance in treatment decision making. We investigated absolute treatment effects according to baseline kidney disease status. STUDY DESIGN: Meta-analysis. STUD...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Kwang Jin, Jung, Hae Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551546/
https://www.ncbi.nlm.nih.gov/pubmed/34746739
http://dx.doi.org/10.1016/j.xkme.2021.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551546/
https://www.ncbi.nlm.nih.gov/pubmed/34746739
http://dx.doi.org/10.1016/j.xkme.2021.04.009

Ejemplares similares